NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
The Turbolift: Linear Sled Hybrid Artificial Gravity ConceptFuture crewed space exploration missions into deep space will require enhanced countermeasure technologies to ensure astronaut health. One such hazard is extended exposure to reduced gravity levels (i.e., microgravity, lunar gravity, or Martian gravity). Reduced gravity negatively impacts many physiological systems, leading to hydrostatic intolerance, musculoskeletal atrophy, sensorimotor impairment, bone demineralization, cardiovascular deconditioning, and visual alterations. Various countermeasures have been employed for mitigating these effects, such as exercise, pharmaceuticals, diet, and fluid loading. However, these approaches treat individual symptoms, such that each physiological system is addressed with typically one countermeasure. An alternative to this approach is artificial gravity (AG), which promises to be a holistic, comprehensive countermeasure. The traditional approach to creating AG is through centrifugation. However, centrifugation is not a "pure" form of AG and typically includes the drawbacks of Coriolis forces, gravity gradients, and vestibular cross-coupled illusions.As an alternative, we have proposed a Linear Sled Hybrid (LSH) AG system to mitigate astronauts' physiological deconditioning. This system functions by applying pure linear acceleration to produce footward loading. There is a half rotation (180_) to reorient the rider between acceleration and deceleration phases, such that the loading remains footward, as when standing on Earth. The rotation also provides some footward acceleration to the lower body through centripetal acceleration; hence the "hybrid" aspect of the design. At the end of the deceleration, the rider than accelerates back in the opposite direction and the sequence repeats.This proposed system could be integrated with future crewed space vehicles in a variety of manners.
Document ID
20190001171
Acquisition Source
Headquarters
Document Type
Other
Authors
Gruber, Jason
(Innovative Medical Solutions Group Laboratories, Inc. Tampa, FL, United States)
Seyedmandani, Kimia
(Colorado Univ. Boulder, CO, United States)
Clark, Torin K.
(Colorado Univ. Boulder, CO, United States)
Date Acquired
March 4, 2019
Publication Date
February 14, 2018
Subject Category
General
Report/Patent Number
HQ-E-DAA-TN58798
Funding Number(s)
CONTRACT_GRANT: NNX17AJ77G
Distribution Limits
Public
Copyright
Use by or on behalf of the US Gov. Permitted.
No Preview Available